RE:RE:RE:RE:RE:Dundee Annual Meeting! Dundee owns 3.2% of TauRx Pharmaceuticals Ltd. TauRx is a non core investment. The catalyst is new drug listing after which Tau goes public and Dundee has exit liquidity. There is a ton of upside.
I love being able to add to my position at a discount to book. I don't see much downside business risk.
Assets are funded through Debt and Equity. Dundees debt like instrument is preferred stock which has same downside risk as normal equity but limited upside. The legacy preferred stock is a cheap source of funding for risky jr mining companies.
By focusing managements efforts on mining where Dundee is traditionaly strongest investors that want Jr and Mid tier mining exposure can invest in Dundee.